Occult hepatitis B in renal transplant patients

Transplant Infectious Disease

Volumn 7, Issue 2, 2005, Pages 51-56

  Peres, A A ^a   Dias, E A ^a   Chesky, M ^a   Alvares Da Silva, M R ^a   Jobim, L F ^a   Goncalves L F ^a   Manfro, Roberto C ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Hepatitis C; Occult hepatitis B; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CYCLOSPORIN A; DNA; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCULT HEPATITIS B; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SERUM;

ADULT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE;

EID: 25144483447     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2005.00091.x     Document Type: Article

References (30)

1. FABRIZI F, BUNNAPRADIST S, MARTIN P. HBV infection in patients with end-stage renal disease. Semin Liver Dis 2004:24 (Suppl 1): 63-70.
2. CENDOROGLO NETO M, DRAIBE SA, SILVA AE, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995:10:240-246.
3. BUSEK SU, BABA EH, TAVARES FILHO HA, et al. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2002:97:775-778.
4. GANEM D, PRINCE AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004:350:1118-1129.
5. CABRERIZO M, BARTOLOME J, DE SEQUERA P, CARAMELO C, CARRENO V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1997:8:1443-1447.
6. CACCIOLA I, POLLICINO T, SQUADRITO G, CERENZIA G, ORLANDO ME, RAIMONDO G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999:341:22-26.
7. CACCIOLA I, POLLICINO T, SQUADRITO G, et al. Quantification of intrahepatic hepatitis B virus (HBV) in patients with chronic HBV infection. Hepatology 2000:1: 507-512.
8. KAZEMI-SHIRAZI L, PETERMANN D, MULLER C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000:33: 785-790.
9. LEE DS, HUH K, LEE EH, LEE DH, HONG KS, SUNG YC. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. Gastroenterol Hepatol 1997:12: 855-861.
10. OESTERREICHER C, HAMMER J, KOCH U, et al. HBVand HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995:48:1967-1971.
11. SHINTANI Y, YOTSUYANAGI H, MORIYA K, et al. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer 2000:88: 2478-2486.
12. NIREI K, KANEKO M, MORIYAMA M, ARAKAWA Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology 2000:43:95-101.
13. BAIN VG. Hepatitis B in transplantation. Transpl Infect Dis 2000:2:153-165.
14. International Interferon-Alfa Hepatocellular Carcinoma Study Group. Effect of interferon-alfa on progression of cirrhosis to hepatocelullar carcinoma: retrospective cohort study. Lancet 1998:351:1535-1539.
15. OLDAKOWSKA-JEDYNAK M, DURLIK M, PACZEK L, et al. Hepatocellular carcinoma development in renal allograft recipients. Transplant Proc 2000:32:1363-1364.
16. CORREA JRM, ROCHA F, PERES AA, GONÇALVES LF, MANFRO RC. Long-term impact of hepatitis B and C virus infection in kidney transplantation recipient's survival. Transplant Proc 2003:35:1076-1077.
17. PRINCE AM, LEE DH, BROTMAN B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001:41:329-332.
18. DURLIK M, GACIONG Z, SOLUCH L, et al. Clinical course of concomitant HBV and HCV infection in renal allograft recipients. Ann Transplant 1996:1:11-12.
19. VALLIAMMAI T, THYAGARAJAN SP, ZUCKERMAN JÁ, HARRISON TJ. Precore and core mutations in HBV from individuals in India with chronic infection. J Med Virol 1995:45:321-325.
20. GROB P, JILG W, BORNHAK H, et al. Serological pattern anti HBc alone: report on workshop. J Med Virol 2000:62:437-455.
21. UCHIDA T, KANEITA Y, GOTOH K, et al. Hepatitis C virus is frequently coinfected with serum marker negative hepatitis B virus: probable replication promotion of the former by the latter as a demonstrated by in vitro cotransfection. J Med Virol 1997:52: 399-405.
22. PORCHON C, KREMSDORF D, POL S, et al. Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis. J Hepatol 1992:16:184-189.
23. Hu K-Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002:9:243-257.
24. TERRAULT AN, WRIGHT LT. Viral hepatitis A through G - hepatitis B virus. Chapter 68. In: FELDMAN M, SCHARASCHMIDT BF, SLEISENGER MH, KLEIN S, eds. Gastrointestinal and Liver Disease - Pathophysiology/Diagnosis/Management, Vol. 2 (6th edn). Philadelphia: W.B. Saunders, 1998:1129-1143.
25. DUHART BT Jr, HONAKER MR, SHOKOUHAMIRI MH, et al. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis 2003:5:126-131.
26. SENGAR DP, COUTURE RA, LAZAROVITS AI, JINDAL SL. Long-term patient and renal allograft survival in HBsAg infection: a recent update. Transplant Proc 1989:21: 3358-3359.
27. GENTIL MA, ROCHA JL, RODRIGUEZ-ALGARRA G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999:14: 2455-2460.
28. MORALES JM, CAMPISTOL JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000:11:1343-1353.
29. BATTY DS Jr, SWANSON SJ, KIRK AD, KO CW, AGODOA LY, ABBOTT KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001:1:179-184.
30. HUANG CC, LIAW YF, LAI MK, CHU SH, CHUANG CK, HUANG JY. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992:53: 763-765.